Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 5.9% Today

What is Hims & Hers Health Inc.?

Hims & Hers Health Inc. (NYSE: HIMS) operates as a telehealth company offering personalized healthcare products and services, amid recent market volatility.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 5.9% on Oct 23, 2024 14:40

• Today's downturn in HIMS stock can be linked to these reasons:
• Shift in market sentiment towards bearishness, potentially driven by profit-taking or adverse developments.
• Adjustment in stock price following a notable upswing in the past month and year, impacting the stock's valuation.
• Differing positions held by institutional investors and large stakeholders, fostering uncertainty and influencing the stock downward.
• Reevaluation of the company's price-to-earnings ratio and basic metrics by the market, prompting a reassessment of the stock's value and growth potential.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Check Out What Whales Are Doing With HIMS - Hims & Hers Health ( NYSE:HIMS )

Deep-pocketed investors have adopted a bearish approach towards Hims & Hers Health HIMS, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.

https://www.benzinga.com/insights/options/24/10/41462113/check-out-what-whales-are-doing-with-hims

A Look Into Hims & Hers Health Inc's Price Over Earnings - Hims & Hers Health ( NYSE:HIMS )

In the current market session, Hims & Hers Health Inc. HIMS stock price is at $22.92, after a 0.56% drop. However, over the past month, the company's stock increased by 32.72%, and in the past year, by 272.08%.

https://www.benzinga.com/insights/news/24/10/41460675/a-look-into-hims-hers-health-incs-price-over-earnings

This Is What Whales Are Betting On Hims & Hers Health - Hims & Hers Health ( NYSE:HIMS )

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

https://www.benzinga.com/insights/options/24/10/41436106/this-is-what-whales-are-betting-on-hims-hers-health

Check Out What Whales Are Doing With HIMS - Hims & Hers Health ( NYSE:HIMS )

Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 16 unusual trades. Delving into the details, we found 62% of traders were bullish, while 31% showed bearish tendencies.

https://www.benzinga.com/insights/options/24/10/41359689/check-out-what-whales-are-doing-with-hims

Trending Today

Ondo ($ONDO) Crypto Forecast: Down 5.0% Today

DexCom Inc. ($DXCM) Stock Forecast: Up 1.8% Today

Lam Research Corporation ($LRCX) Stock Forecast: Up 5.5% Today

Sui ($SUI) Crypto Forecast: Down 5.6% Today

Sabre Corporation ($SABR) Stock Forecast: Up 5.3% Today

BOOK OF MEME ($BOME) Crypto Forecast: Down 5.1% Today

Wormhole ($W) Crypto Forecast: Down 5.9% Today

Equinix Inc. ($EQIX) Stock Forecast: Up 5.1% Today

Sunrun Inc. ($RUN) Stock Forecast: Up 5.2% Today

FuelCell Energy ($FCEL) Stock Forecast: Up 3.8% Today

Hims & Hers Health Inc. Price History

08.09.2024 - HIMS Stock was down 5.3%

• The stock exhibited significant bearish momentum, possibly reflecting profit-taking following a recent surge supported by expectations of inclusion in the S&P SmallCap 600 index.
• Initial bullish support from major financial institutions could have influenced the stock's rise, but heightened bearish sentiment among traders likely led to the downturn.
• The stock's decline, possibly influenced by market sympathy towards Eli Lilly And Co, contributed to the prevailing bearish sentiment among investors.
• Unfavorable trends in earnings forecast revisions possibly hindered upward movement in the stock's near-term trajectory, contributing to the bearish trend.

10.09.2024 - HIMS Stock was down 5.5%

• Hims & Hers Health, Inc. (HIMS) witnessed a notable decline despite recent positive developments and optimism from major financial institutions.
• The stock initially saw an uptick in response to expectations of inclusion in the S&P SmallCap 600 this week. However, market sentiment took a turn, leading to the bearish movement.
• Factors such as conflicting signals from earnings estimate changes and overshadowing company news by other market influences likely contributed to the stock's downward trend.
• The bearish movement might also be attributed to traders capitalizing on profits following previous bullish sentiment, particularly after a period of heightened trading activity and scrutiny.

21.09.2024 - HIMS Stock was up 5.3%

• The bullish movement in Hims & Hers Health (HIMS) stock today can be attributed to the significant bullish stance taken by investors with substantial capital, as evidenced by the unusual bullish trades in the options market.
• The confidence shown by financial giants in HIMS, with 62% of traders displaying bullish sentiments, likely contributed to the positive momentum in the stock.
• The FDA's decision to reconsider the removal of Lilly's obesity drug from the shortage list may have also positively influenced investor sentiment in the healthcare sector, indirectly benefiting companies like Hims & Hers Health operating in the telehealth space.

16.09.2024 - HIMS Stock was up 6.8%

• Strong bullish activity was observed from financial institutions towards Hims & Hers Health, with a majority of traders exhibiting bullish sentiment.
• The FDA reevaluating the ban on drug compounders producing their versions of weight loss medications, which includes products from Hims & Hers Health, was likely a contributing factor to the bullish market movement.
• This regulatory update served as a positive trigger for HIMS stock, leading to a significant increase in its value.
• Amidst general market growth, Hims & Hers Health stock notably outperformed, experiencing a substantial rise attributable to the favorable regulatory news.

15.09.2024 - HIMS Stock was up 10.7%

• HIMS stock rose following the FDA's decision to reconsider the ban on drug compounders selling their versions of weight loss medications, including a popular drug. This decision sparked investor optimism.
• The FDA's decision to permit compounding pharmacies to continue producing certain drugs likely bolstered investor confidence in HIMS's potential for future growth in the health and wellness sector.
• Despite the general market upswing, HIMS stock experienced a significant bullish trend, suggesting that the FDA's regulatory changes had a positive impact on the company's stock performance.

03.09.2024 - HIMS Stock was down 9.6%

• Hims & Hers Health (HIMS) stock experienced a notable decline, which could be related to recent developments involving a competitor being removed from the weight-loss and diabetes drugs shortage list by the U.S. Food and Drug Administration, impacting the healthcare sector sentiment negatively.
• Despite the overall bearish trend in the market, there was observed an increase in options trading activity as major financial players made bullish moves on HIMS, reflecting a mixed sentiment within the trading community.
• The conflicting signals from the options market, along with the adverse news related to a competitor's FDA status, likely influenced the downward pressure on Hims & Hers Health stock performance.

03.09.2024 - HIMS Stock was down 10.3%

• The stock of Hims & Hers Health (HIMS) experienced a strong bearish movement today.
• The bullish move by financial giants and the majority of traders being bullish on HIMS options contrast with the bearish stock movement, indicating a disconnect between sentiment and actual market performance.
• The stock's tumble might be attributed to sympathy trading with Eli Lilly And Co (LLY) after the U.S. FDA removed it from the weight-loss and diabetes drugs shortage list, possibly leading investors to reallocate funds from HIMS to other more promising opportunities in the pharmaceutical sector.
• This divergence in market sentiment and external factors impacting the healthcare industry could have contributed to the bearish movement in HIMS stock today.

04.09.2024 - HIMS Stock was up 6.7%

• The strong bullish movement in HIMS today could be attributed to the conspicuous bullish move made by financial giants in the stock, as indicated by the unusual options trades and the majority of traders showing bullish tendencies.
• The stock might have also benefited from positive market sentiment as indicated by the overall bullish market movement.
• The dip in HIMS shares due to sympathy with Eli Lilly And Co's news might have been short-lived, as the stock managed to recover and close the day with a strong bullish movement.
• Overall, the combination of positive market sentiment, bullish moves by financial giants, and a temporary dip due to external factors contributed to the strong bullish movement in HIMS today.

15.09.2024 - HIMS Stock was up 5.4%

• The positive movement in HIMS stock is believed to be linked to recent developments by the U.S. Food and Drug Administration reconsidering its decision, potentially favoring drug compounders such as Hims & Hers Health to market their own versions of well-known weight loss medications.
• This development likely instilled a sense of positivity and confidence among investors in the company's future earnings and expansion prospects, contributing to the stock's upward momentum.
• Amid broader market advances, HIMS stock demonstrated notable strength in its climb, signaling that the specific regulatory news about the FDA's decision played a critical role in propelling the stock's value upward.

01.09.2024 - HIMS Stock was up 5.1%

• The strong bullish movement in HIMS stock could be attributed to financial giants making a conspicuous bullish move on the company, as indicated by the analysis of options history.
• The high percentage of traders showing bullish tendencies (44%) compared to bearish ones (33%) may have further fueled the positive momentum in the stock.
• The options frenzy surrounding Hims & Hers Health could have created a sense of optimism and excitement among investors, driving up the stock price significantly.

08.09.2024 - HIMS Stock was down 5.1%

• HIMS stock experienced a strong bearish movement, possibly due to profit-taking after the recent bullish momentum.
• The company joining the S&P SmallCap 600 this week may have initially boosted investor sentiment, leading to a surge in the stock price.
• However, the stock's decline could be attributed to profit-taking, as well as potential market sympathy with Eli Lilly And Co's stock movement following FDA news.
• The options trading activity showing a higher bullish sentiment might indicate a positive long-term outlook for HIMS despite the short-term bearish movement.

23.09.2024 - HIMS Stock was down 5.9%

• Today's downturn in HIMS stock can be linked to these reasons:
• Shift in market sentiment towards bearishness, potentially driven by profit-taking or adverse developments.
• Adjustment in stock price following a notable upswing in the past month and year, impacting the stock's valuation.
• Differing positions held by institutional investors and large stakeholders, fostering uncertainty and influencing the stock downward.
• Reevaluation of the company's price-to-earnings ratio and basic metrics by the market, prompting a reassessment of the stock's value and growth potential.